Cleared Traditional

K072123 - HOMEWAVE NEUROMODULATIONS PAIN THERAPY DEVICE

K072123 is an FDA 510(k) clearance for HOMEWAVE NEUROMODULATIONS PAIN THERAPY ..., manufactured by Biowave Corporation. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 183-day FDA review.

K072123 · Biowave Corporation · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2008
Decision
183d
Days
Class 2
Risk

K072123 is an FDA 510(k) clearance for the HOMEWAVE NEUROMODULATIONS PAIN THERAPY DEVICE. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Biowave Corporation (North Attleboro, US). The FDA issued a Cleared decision on February 1, 2008 after a review of 183 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Biowave Corporation devices

FDA 510(k) Submission Details - K072123

510(k) Number K072123 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 2007
Decision Date February 01, 2008
Days to Decision 183 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d slower than avg
Panel avg: 149d · This submission: 183d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 329
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K072123.
KFH ENERGY, MODEL: E1
K073008 · Kingfisher Healthcare NV · Mar 2008
TENS/IF 14
K071869 · Emsi · Mar 2008
PROSTIM 1000/2000
K073438 · Bio Protech, Inc. · Feb 2008
DELTA SCANNER, DELTA SCANNER PRO, DS SPINE PRO, DS SPORTS PRO AND DS REHAB
K071878 · Med-Lectric Corporation · Dec 2007
EVERELIFE TRANSCUTANEOUS MUSCLE STIMULATOR
K071624 · Everlife Medical Equipment Co., Ltd. · Nov 2007
NEURO WAVE 6
K062003 · Lhasa Oms, Inc. · Sep 2007